Stuart Richards

Stuart Richards

Partner

Stuart Richards is a partner in Fasken Martineau LLP (London) and a member of the Technology and Intellectual Property and Life Sciences practice groups.

Stuart specialises in representing a variety of pharmaceutical, biotechnology and medical device companies with a particular emphasis on the needs of drug delivery companies. He advises on a broad range of transactions, including inbound and outbound licensing, development deals, research and development collaborations, manufacture and supply arrangements, distribution agreements and clinical trials agreements , as well as all aspects of pharmaceutical regulatory law and practice, including data exclusivity, Bolar exemptions, medical device regulation and PPRS. In 2005, Stuart was seconded to SkyePharma Plc for a year during which time he dealt with a wide range of commercial transactions for the client and its Swiss and American subsidiaries. With Allistair Booth, Stuart is the firm's representative of Biolegis, its European wide network of life sciences specialist law firms (see www.BioLegis.net).

Stuart has extensive experience representing clients in EU and UK competition work, including advising on anti-competitive agreements, dominance, pricing practices and parallel trade (including repackaging and relabelling, distribution systems and restrictions on supply). In addition he advises on merger referrals and clearances. Stuart advises on the protection and exploitation of intellectual property for clients in a wide range of industries and provides general commercial and contractual advice, including carrying out and coordinating contractual and IP due diligence. For a number of years Stuart has advised a UK-registered charity in relation to contractual and commercial issues, including IP licensing, marketing agreements, fundraising and sponsorship agreements.

Selected Experience

Publications

Presentations

Membership/Affiliations